Doki Y - Search Results

1

MicroRNAs Induce Epigenetic Reprogramming and Suppress Malignant Phenotypes of Human Colon Cancer Cells.

Ogawa H, Wu X, Kawamoto K, Nishida N, Konno M, Koseki J, Matsui H, Noguchi K, Gotoh N, Yamamoto T, Miyata K, Nishiyama N, Nagano H, Yamamoto H, Obika S, Kataoka K, Doki Y, Mori M, Ishii H. Ogawa H, et al. Among authors: doki y. PLoS One. 2015 May 13;10(5):e0127119. doi: 10.1371/journal.pone.0127119. eCollection 2015. PLoS One. 2015. PMID: 25970424 Free PMC article.

2

Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.

Shamma A, Yamamoto H, Doki Y, Okami J, Kondo M, Fujiwara Y, Yano M, Inoue M, Matsuura N, Shiozaki H, Monden M. Shamma A, et al. Among authors: doki y. Clin Cancer Res. 2000 Apr;6(4):1229-38. Clin Cancer Res. 2000. PMID: 10778945

3

Overexpression of CDC25B overrides radiation-induced G2-M arrest and results in increased apoptosis in esophageal cancer cells.

Miyata H, Doki Y, Yamamoto H, Kishi K, Takemoto H, Fujiwara Y, Yasuda T, Yano M, Inoue M, Shiozaki H, Weinstein IB, Monden M. Miyata H, et al. Among authors: doki y. Cancer Res. 2001 Apr 1;61(7):3188-93. Cancer Res. 2001. PMID: 11306507

4

Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.

Nishioka K, Doki Y, Shiozaki H, Yamamoto H, Tamura S, Yasuda T, Fujiwara Y, Yano M, Miyata H, Kishi K, Nakagawa H, Shamma A, Monden M. Nishioka K, et al. Among authors: doki y. Br J Cancer. 2001 Aug 3;85(3):412-21. doi: 10.1054/bjoc.2001.1934. Br J Cancer. 2001. PMID: 11487274 Free PMC article.

5

Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.

Nakamura M, Nagano H, Noda T, Wada H, Ota H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Doki Y, Umeshita K, Dono K, Sakon M, Monden M. Nakamura M, et al. Among authors: doki y. Hepatol Res. 2006 Aug;35(4):289-95. doi: 10.1016/j.hepres.2006.04.014. Epub 2006 Jun 12. Hepatol Res. 2006. PMID: 16769246

6

Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers.

Ota H, Nagano H, Doki Y, Sekimoto M, Kondo M, Wada H, Nakamura M, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Wakasa K, Sakon M, Monden M. Ota H, et al. Among authors: doki y. Oncol Rep. 2006 Aug;16(2):249-55. Oncol Rep. 2006. PMID: 16820899

7

Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.

Damdinsuren B, Nagano H, Wada H, Kondo M, Ota H, Nakamura M, Noda T, Natsag J, Yamamoto H, Doki Y, Umeshita K, Dono K, Nakamori S, Sakon M, Monden M. Damdinsuren B, et al. Among authors: doki y. Int J Oncol. 2007 Jan;30(1):201-8. Int J Oncol. 2007. PMID: 17143530

8

Interferon alpha receptors are important for antiproliferative effect of interferon-alpha against human hepatocellular carcinoma cells.

Damdinsuren B, Nagano H, Wada H, Noda T, Natsag J, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Monden M. Damdinsuren B, et al. Among authors: doki y. Hepatol Res. 2007 Jan;37(1):77-83. doi: 10.1111/j.1872-034X.2007.00007.x. Hepatol Res. 2007. PMID: 17300701

9

Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.

Wada H, Nagano H, Yamamoto H, Arai I, Ota H, Nakamura M, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Nakamori S, Sakon M, Monden M. Wada H, et al. Among authors: doki y. Oncol Rep. 2007 Oct;18(4):801-9. Oncol Rep. 2007. PMID: 17786339

10

Long-term and short-term evaluation of esophageal reconstruction using the colon or the jejunum in esophageal cancer patients after gastrectomy.

Doki Y, Okada K, Miyata H, Yamasaki M, Fujiwara Y, Takiguchi S, Yasuda T, Hirao T, Nagano H, Monden M. Doki Y, et al. Dis Esophagus. 2008;21(2):132-8. doi: 10.1111/j.1442-2050.2007.00738.x. Dis Esophagus. 2008. PMID: 18269648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,636 results

Search Page

Filters